Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Background Gaining further insights into SARS-CoV-2 routes of infection and the underlying
pathobiology of COVID-19 will support the design of rational treatments targeting the life …
pathobiology of COVID-19 will support the design of rational treatments targeting the life …
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
Human immunology and immunotherapy: main achievements and challenges
J Varadé, S Magadán… - Cellular & Molecular …, 2021 - nature.com
The immune system is a fascinating world of cells, soluble factors, interacting cells, and
tissues, all of which are interconnected. The highly complex nature of the immune system …
tissues, all of which are interconnected. The highly complex nature of the immune system …
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and …
COVID‐19 is highly contagious pathogenic viral infection initiated from Wuhan seafood
wholesale market of China on December 2019 and spread rapidly around the whole world …
wholesale market of China on December 2019 and spread rapidly around the whole world …
Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
Z Shao, Y Feng, L Zhong, Q Xie, M Lei… - Clinical & …, 2020 - Wiley Online Library
Abstract Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …
Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the cause of the novel
coronavirus disease 2019 (COVID‐19), a highly pathogenic and sometimes fatal respiratory …
coronavirus disease 2019 (COVID‐19), a highly pathogenic and sometimes fatal respiratory …
Targeting human TLRs to combat COVID‐19: a solution?
R Patra, N Chandra Das… - Journal of medical …, 2021 - search.ebscohost.com
Targeting human TLRs to combat COVID-19: A solution? The recent publication by
Choudhury and Mukherjee1 in this journal depicted the interactions of severe acute …
Choudhury and Mukherjee1 in this journal depicted the interactions of severe acute …
Symptomatic protective action of glycyrrhizin (licorice) in COVID-19 infection?
H Murck - Frontiers in immunology, 2020 - frontiersin.org
The role of the ACE2 enzyme in the COVID-19 infection is 2-fold, with opposing implications
for the disease development. 1. The membrane bound angiotensin converting enzyme 2 …
for the disease development. 1. The membrane bound angiotensin converting enzyme 2 …
Flattening the COVID-19 curve with natural killer cell based immunotherapies
M Market, L Angka, AB Martel, D Bastin… - Frontiers in …, 2020 - frontiersin.org
Natural Killer (NK) cells are innate immune responders critical for viral clearance and
immunomodulation. Despite their vital role in viral infection, the contribution of NK cells in …
immunomodulation. Despite their vital role in viral infection, the contribution of NK cells in …